Fundraising Fox
🦊/People
Sign in

Andrew Hack

Investor

Partner, Life Sciences at Bain Capital Life Sciences · Board director at Nuvalent · Executive at Editas Medicine

Boston

Find your path to Andrew

450 people in our graph share verified history with Andrew — schools, employers, funds. One of them is your warm intro.

Elena PantaziunlockedAndrew: together at Bain Capital (2019)
×4Andrew: together at Bain Capital
×4Andrew: together at University of Chicago
×3Andrew: together at Mpmcapital

About

Andrew Hack is a Partner on the Life Sciences team at Bain Capital, which he joined in 2019. He previously served as Chief Financial Officer of Editas Medicine and as a portfolio manager at Millennium Management running a market-neutral healthcare hedge fund, and earlier worked as a securities analyst at healthcare-focused hedge funds and banks and as Director of Life Sciences at Reify Corporation. He holds an MD and PhD in molecular genetics and cell biology and an AB in biology, all from the University of Chicago.

Invests in

Biotech

Board director at Nuvalent

Intro paths

→

In turn, Andrew can intro founders to Nuvalent's investors below.

Nuvalent's investors · 2

Avoro Capital AdvisorsNew York · since 2021Bain Capital Life SciencesBoston · since 2021

Co-founders at Nuvalent

MSMatthew Shair
Matthew ShairDirector
HP
Henry Pelish, PhDChief Scientific Officer

Executive at Editas Medicine

Intro paths

→

In turn, Andrew can intro founders to Editas Medicine's investors below.

Editas Medicine's investors · 6

Deerfield Management CompanyNew York · since 2015EcoR1 CapitalSan Francisco · since 2015Flagship VenturesCambridge · since 2015National Institutes of Health (NIH)since 2015Polaris PartnersBoston · $500K – $5M checks · since 2013Sofinnova VenturesMenlo Park · $100K – $15M checks · since 2015

Co-founders at Editas Medicine

FZFeng Zhang
Feng ZhangScientific Founder, Core Member, Broad Institute of MIT and Harvard
GCGeorge Church
George ChurchScientific Founder, Professor of Genetics, Harvard University and MIT
KJ
Keith JoungScientific Founder, Professor of Pathology, Harvard Medical School
DLDavid Liu
David LiuScientific Founder, Professor of Chemistry and Chemical Biology, Harvard University

Experience

  1. Bain CapitalPartnercurrent2019 — presentBoston, MA
  2. Editas MedicineChief Financial Officer2015 — 2019Cambridge, Massachusetts
  3. Millennium ManagementPortfolio Manager2011 — 2015New York, United States
  4. HealthCor ManagementAnalyst2008 — 2011New York, United States
  5. Carlyle-Blue Wave PartnersAnalyst2007 — 2008New York, United States
  6. MPM CapitalPrincipal2006 — 2007San Francisco, California, United States
  7. Bank of America and Rodman & RenshawBiotechnology Analyst2004 — 2006New York, United States
  8. Reify CorporationDirector of Life Sciences2002 — 2004Cambridge, Massachusetts, United States

Deals · 2

Xilio TherapeuticsBoard seat

via Bain Capital Life Sciences · filed Feb 2021 · $95M raise

JenaValveBoard seat

via Bain Capital Life Sciences · filed Oct 2020 · $66.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Bain Capital Life Sciences

Adam Fogel
Vice President at Bain Capital Credit
Adam M. Koppel
Managing Director at Bain Capital Life Sciences
Alexander Evans
Partner at Bain Capital Crypto
Alyson Goff
Associate at Bain Capital Life Sciences
Amarilice Young
Associate General Counsel at Bain Capital Life Sciences
Amir Zamani
Partner at Bain Capital Life Sciences
Andrew Carlino
Partner at Bain Capital Credit
Benjamin Nye
Managing Partner at Venture Guides Management, L.P.

Frequently asked questions

Who is Andrew Hack?
Andrew Hack is a Partner on the Life Sciences team at Bain Capital, which he joined in 2019. He previously served as Chief Financial Officer of Editas Medicine and as a portfolio manager at Millennium Management running a market-neutral healthcare hedge fund, and earlier worked as a securities analyst at healthcare-focused hedge funds and banks and as Director of Life Sciences at Reify Corporation. He holds an MD and PhD in molecular genetics and cell biology and an AB in biology, all from the University of Chicago.
Where does Andrew Hack work?
Andrew Hack is Partner, Life Sciences at Bain Capital Life Sciences and Board director at Nuvalent and Executive at Editas Medicine.
What does Andrew Hack invest in?
Andrew Hack invests in Biotech.
What boards does Andrew Hack sit on?
Andrew Hack holds tracked board seats at JenaValve, Xilio Therapeutics.
Where did Andrew Hack go to school?
Andrew Hack studied at The University of Chicago Pritzker School of Medicine (M.D., Medicine); University of Chicago (Ph.D., Molecular Genetics and Cell Biology); University of Chicago (A.B., Biology).

Same school

Shared employers